InvestorsHub Logo
Followers 104
Posts 13811
Boards Moderated 0
Alias Born 12/26/2012

Re: BioPharma post# 4561

Monday, 12/18/2017 11:51:19 PM

Monday, December 18, 2017 11:51:19 PM

Post# of 5006
Means nothing...could simply be more toxic notes, debt holders love to short and cover with discounted shares received from the company. But, either way, the market has clearly spoken and the perpetual downtrend remains set. Also, don't forget this it is failed company, printing shares at every turn, and, of course, they have no choice but to perform an RS on or before 1/19/18 (10 days prior to the second extension expiration) in order to remain on the Nasdaq. So, those are the actual facts, as a result of managements failure to deliver. Should someone short, it's solely due to the market realizing corporate weakness, nothing else. Maybe they'll have 10 consecutive days over $1 before the 19th of January, but, better start soon, only 21 trading days left...otherwise, might bounce post RS, wait for the drop following though, no hurry to catch a falling knife...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News